Introduction
============

Congenital cataract, the loss of eye lens transparency, is a significant cause of visual impairment or blindness in childhood. The prevalence of congenital cataracts is 1 to 6 per 10,000 live births, depending on the ascertainment method \[[@r1]\]. Globally, congenital cataracts account for nearly one-tenth of childhood blindness from different causes including infections during embryogenesis, metabolic disorders (galactosemia), and genetic defects \[[@r2]\].Statistical analyses have revealed that about one quarter of congenital cataracts are hereditary \[[@r3]\].Genetically, the majority of isolated congenital cataracts exhibit as autosomal dominant, although autosomal recessive and X-linked inherited forms have also been reported \[[@r4]\].

Over the past few years, remarkable progress has been made toward our understanding of the cataractogenesis process. Currently, there are more than 40 genetic loci to which isolated or primary cataracts have been mapped, and more than 26 genes have been characterized, although this number is constantly increasing \[[@r5]\]. Autosomal dominant congenital cataracts (ADCC) was reportedly caused by mutations in different genes \[[@r2]\]. Approximately half of the mutations are in the crystallin genes and a quarter in connexin genes, with the remainder divided among genes that encode heat shock transcription factor-4 (*HSF4*), aquaporin-0 (*AQP0, MIP*), paired-like homeodomain 3 (*PITX3*), v-maf musculoaponeurotic fibrosarcoma oncogene homolog (*MAF*), chromatin modifying protein (*CHMP4B*), lens intrinsic membrane protein 2 (*LIM2*), beaded filament structural protein-2 (*BFSP2*), and other genes \[[@r2],[@r6]\]. The crystallin and connexin genes appear to be the most commonly associated with congenital cataract. So, it is suitable to consider these genes as the top candidates for developing congenital cataracts screening strategies.

Congenital cataracts can be classified into several subtypes according to morphology: total, nuclear, cortical, anterior polar, posterior polar, lamellar, cerulean, pulverulent, sutural, coralliform, wedge-shaped, and polymorphic cataracts and other minor subtypes \[[@r2]\].Congenital cataracts are genetically heterogeneous \[[@r7]\]. It is known that different mutations in different genes can cause similar cataract patterns, while the highly variable cataract morphologies within some families suggest that the same mutation in a single gene can lead to different phenotypes \[[@r8],[@r9]\].

In this paper, a four-generation family affected with congenital polymorphic cataracts was investigated in an attempt to identify the genetic defect associated with their cataract phenotype.

Methods
=======

Clinical evaluations and DNA specimens
--------------------------------------

Four generations of a family suffering with ADCC were recruited from the Eye Center of Affiliated Second Hospital, College of Medicine, Zhejiang University, Hangzhou, China. Informed consent was obtained from all participants in accordance with the Zhejiang Institutional Review Board and the study protocol adhered to the tenets of the Declaration of Helsinki. In total, 11 individuals participated: 7 affected and 4 unaffected ([Figure 1](#f1){ref-type="fig"}). Detailed medical histories were obtained by interviewing all individuals. All participants underwent detailed ophthalmic examinations including visual acuity, slit lamp examination with dilated pupils, ultrasonography, fundus exam, and intraocular pressure measurement. The phenotypes were documented using slit lamp photography ([Figure 2](#f2){ref-type="fig"}). Also,100 unrelated ethnically-matched controls with no family history of congenital cataracts were recruited.

![Pedigree of the autosomal dominant congenital cataract mutation. The proband is marked with an arrow. Squares and circles indicate males and females, respectively. Black and white symbols represent affected and unaffected individuals, respectively. The asterisks indicate family members who attend this study.](mv-v18-2213-f1){#f1}

![Slit-lamp photograph of family members with congenital cataracts. **A**, **B**: The proband (II:1) had nuclear cataract with \'Y\' sutural opacities. **C**, **D**: The affected member IV:2 showed a different zonular cataract with \'Y\' sutural opacities. **E**: The affected member IV:1 had simple \'Y\' sutural opacities. **F**-**H**: The affected member III:3 had slight nuclear cataract with curd-like peripheral cortical opacities.](mv-v18-2213-f2){#f2}

About 2 ml of peripheral blood was collected from the family members and the controls who took part in the study. Blood samples were obtained by venipuncture, collected in Vacutainer tubes (Becton-Dickinson, Franklin Lakes, NJ) containing ethylene diamine tetraacetic acid (EDTA). Leukocyte genomic DNA was extracted using the QIAmp Blood kit (Qiagen, Duesseldorf, Germany).

Mutation analysis
-----------------

Genomic DNA samples from affected and unaffected members of the family were screened for mutations in crystallin alpha A (*CRYAA*), crystallin alpha B (*CRYAB*), crystallin beta A3/A1 (*CRYBA3/1*), crystallin beta B2 (*CRYBB2*), crystallin gamma C (*CRYGC*), crystallin gamma D (*CRYGD*), gap junction protein, alpha 3 (*GJA3*), and gap junction protein, alpha 8 (*GJA8*) genes using direct sequencing. The coding regions of candidate genes were amplified using polymerase chain reaction (PCR) with previously published primer sequences ([Table 1](#t1){ref-type="table"}) \[[@r10]-[@r17]\]. The cycling conditions for PCR were 95 °C pre-activation for 5 min, 10 cycles of touchdown PCR with a 0.5 °C down per 60 °C to 55 °C cycle, followed by 30 cycles with denaturation at 95 °C for 25 s, annealing at 55 °C for 25 s, and extension at 72 °C for 40 s. PCR products were isolated using electrophoresis on 3% agarose gels and sequenced using the BigDye Terminator Cycle sequencing kit V 3.1 (ABI--Applied Biosystems; Sangon Co, China) on an ABI PRISM 3730 Sequence Analyzer (ABI), according to the manufacturer's instructions. Sequencing results were analyzed using [Chromas 1.62](http://www.technelysium.com.au/chromas.html) and compared with sequences from NCBI [GenBank](http://www.ncbi.nlm.nih.gov/genbank/) (*CRYAA*: 21q22.3; [NM_000394](http://www.ncbi.nlm.nih.gov/nuccore/NM_000394), *CRYAB*: 11q22; [NG_009824](http://www.ncbi.nlm.nih.gov/nuccore/NG_009824), *CRYBA1*: 17q11-q12; [NM_005208](http://www.ncbi.nlm.nih.gov/nuccore/NM_005208), *CRYBB2*: 22q11.2; [NM_000496](http://www.ncbi.nlm.nih.gov/nuccore/NM_000496), *CRYGC*: 2q33-q35; [NM_020989](http://www.ncbi.nlm.nih.gov/nuccore/NM_020989), *CRYGD*: 2q33-q35; [NM_006891.3](http://www.ncbi.nlm.nih.gov/nuccore/NM_006891.3), *GJA3:* 13q11-q13; [NM_021954](http://www.ncbi.nlm.nih.gov/nuccore/NM_021954), and *GJA8:* 1q21-q25; [NM_005267](http://www.ncbi.nlm.nih.gov/nuccore/NM_005267)).Direct sequencing was also used to screen the mutation identified in *CRYBA1*on 100 ethnically-matched controls to confirm the mutation.

###### Polymerase chain reaction primers and product sizes.

  **Name**         **Primer sequence (5′-3′)**            **Product size (bp)**
  ---------------- -------------------------------------- -----------------------
  ***CRYBA3/1***                                          
  Exon-1 F         5′GGCAGAGGGAGAGCAGAGTG 3′              207
  Exon-1 R         5′CACTAGGCAGGAGAACTGGG 3′               
  Exon-2 F         5′AGTGAGCAGCAGAGCCAGAA 3′              293
  Exon-2 R         5′GGTCAGTCACTGCCTTATGG 3′               
  Exon-3 F         5′AAGCACAGAGTCAGACTGAAGT 3′            269
  Exon-3 R         5′CCCCTGTCTGAAGGGACCTG 3′               
  Exon-4 F         5′GTACAGCTCTACTGGGATTG 3′              357
  Exon-4 R         5′ACTGATGATAAATAGCATGAACT 3′            
  Exon-5 F         5′GAATGATAGCCATAGCACTAG 3′             290
  Exon-5 R         5′TACCGATACGTATGAAATCTGA 3′             
  Exon-6 F         5′CATCTCATACCATTGTGTTGAG 3′            295
  Exon-6 R         5′GCAAGGTCTCATGCTTGAGG 3′               
  ***CRYAA***                                             
  Exon-1 F         5′CTTAATGCCTCCATTCTGCT 3′              593
  Exon-1 R         5′TGGCTGGTGCCTTACAAA 3′                 
  Exon-2 F         5′ CACCTGACCATAGCCAAACAAC 3′           512
  Exon-2 R         5′ TCTCCCAGGGTTGAAGGCA 3′               
  Exon-3 F         5′ GGGGCATGAATCCATAAATC 3′             487
  Exon-3 R         5′ GGAAGCAAAGGAAGACAGACAC 3′            
  ***CRYAB***                                             
  Exon-1 F         5′ AACCCCTGACATCACCATTC 3′             469
  Exon-1 R         5′ GGAGGAAGGCACTAGCAACC 3′              
  Exon-2 F         5′ TGCAGAATAAGACAGCACCTG 3′            296
  Exon-2 R         5′ AATGTAGCCAGCCTCCAAAG 3′              
  Exon-3 F         5′ TCTGCCTCTTTCCTCATT 3′               473
  Exon-3 R         5′ CCTTGGAGCCCTCTAAAT 3′                
  ***CRYBB2***                                            
  Exon-2 F         5′ TGCTCTCTTTCTTTGAGTAGACCTC 3′        385
  Exon-2 R         5′CCCATTTTACAGAAGGGCAAC 3′              
  Exon-3 F         5′ ACCCTTCAGCATCCTTTG G 3′             314
  Exon-3 R         5′ GCAGACAGGAGCAAGGGTAG 3′              
  Exon-4 F         5′ GCTTGGAGTGGAACTGACCTG 3′            244
  Exon-4 R         5′ GGCAGAGAGAGAAAGTAGGATGATG 3′         
  Exon-5 F         5′ GCCCCCTCACCCATACTC 3′               242
  Exon-5 R         5′ CCCCAGAGTCTCAGTTTCCTG 3′             
  Exon-6 F         5′ CCTAGTGGCTTATGGATGCTC 3′            347
  Exon-6 R         5′ TCTTCACTTGGAGGTCTGGAG 3′             
  ***CRYGC***                                             
  Exon-1.2 F       5′ TGCATAAAATCCCCTTACCGCTGA 3′         524
  Exon-1.2 R       5′ ACTCTGGCGGCATGATGGAAATC 3′           
  Exon-3 F         5′AGACTCATTTGCTTTTTTCCATCCTTCTTTC 3′   407
  Exon-3 R         5′GAAAGAATGACAGAAGTCAGCAATTGCC 3′       
  ***CRYGD***                                             
  Exon-1.2 F       5′ CCTCGCCTTGTCCCGC 3′                 340
  Exon-1.2 R       5′ TTAACTTTTGCTTGAAACCATCCA 3′          
  Exon-3 F         5′ TGCTTTTCTTCTCTTTTTATTTCTGGGTCC 3′   400
  Exon-3 R         5′AGTAAAGAAAGACACAAGCAAATCAGTGCC 3′     
  ***GJA3***                                              
  Exon-1--1 F      5′ CTCTTCTGGCTCTGGCTTCC 3′             741
  Exon-1--1R       5′ CACCTCGAACAGCGTCTTGA 3′              
  Exon-1--2 F      5′ CTTCCCCATCTCCCACATCC 3′             749
  Exon-1--2 R      5′ GGTGGCCGTTGTAGAGCTTG 3′              
  Exon-1--3 F      5′ TCCGCCAAGCTCTACAACG 3′              535
  Exon-1--3 R      5′ GAAACCTGATCTCTCCTCCAT 3′             
  ***GJA8***                                              
  Exon-2--1 F      5′ CAGATATTGACTCAGGGTTG 3′             542
  Exon-2--1R       5′ GATGATGTGGCAGATGTAGG 3′              
  Exon-2--2 F      5′ GGCAGCAAAGGCACTAAG 3′               465
  Exon-2--2 R      5′ CTCCACCATCCCAACCTC 3′                
  Exon-2--3 F      5′ ATCGTTTCCCACTATTTCC 3′              492
  Exon-2--3 R      5′ GGCGTCACTTCATACGGTTA 3′              

Results
=======

Clinical evaluations
--------------------

The cataract exhibited an autosomal dominant inheritance pattern in the family ([Figure 1](#f1){ref-type="fig"}).Three of the seven patients had undergone lens surgery. All affected patients had bilateral lens opacification, but the degree of lens opacities was highly variable ([Figure 2](#f2){ref-type="fig"}).The proband (II:1), who was a 59-year-old woman, had nuclear cataract with 'Y' sutural opacities ([Figure 2A,B](#f2){ref-type="fig"}).The affected member III:3 ([Figure 2F-H](#f2){ref-type="fig"}), who was the daughter of the proband, had slight nuclear cataract with curd-like peripheral cortical opacities, while her son (IV:2; [Figure 2C,D](#f2){ref-type="fig"}) showed a different zonular cataract with 'Y' sutural opacities. The affected member IV:1([Figure 2E](#f2){ref-type="fig"}) had a simple 'Y' sutural opacity. The clinical evaluation of the affected individuals is provided in [Table 2](#t2){ref-type="table"}. Prior to surgery, the affected members had visual acuity ranging from 0.05 to 0.8. After surgery, all patients achieved a best-corrected visual acuity of 0.8 to 1.0. There was no family history of other ocular or systemic abnormalities.

###### Clinical features of affected individuals.

  **Affected individual**   **Gender**   **Age**   **Surgery age**   **Phenotype**
  ------------------------- ------------ --------- ----------------- -------------------------------------------------------------------------------
  II:1                      Female       59        59                Nuclear cataract with 'Y' sutural opacities
  II:4                      Male         55        43                IOL, after cataract surgery
  II:6                      Male         53        41                IOL, after cataract surgery
  III:1                     Female       34        29                IOL, after cataract surgery
  III:3                     Female       33        No surgery        Nuclear cataract with curd-like peripheral cortical opacities
  IV:1                      Female       6         No surgery        'Y' sutural opacities
  IV:2                      Male         8         8                 zonular cataract with 'Y' sutural opacities and peripheral cortical opacities

Mutation screening
------------------

Through bidirectional sequencing of the coding regions of the candidate genes, we identified a c.215+1G\>A substitution in the donor splice site of intron 3 in *CRYBA3/A1* in all affected individuals ([Figure 3](#f3){ref-type="fig"}) that co-segregated with all affected individuals, whereas this heterozygous mutation was not present in the unaffected family members, nor in 100 unrelated Chinese without cataracts who served as controls.

![Forward and reverse sequence analyses of the affected and unaffected individuals in the ADCC Chinese family, showing a c.215+1G\>A mutation of *CRYBA3/A1* (black arrows).](mv-v18-2213-f3){#f3}

Discussion
==========

In this study, we identified a splice site mutation within *CRYBA3/A1* in a four-generation Chinese pedigree with autosomal dominant polymorphic cataract.

Crystallins are known to constitute about 90% of the water-soluble proteins of the lens and contribute to transparency and refractive properties by forming a uniform concentration gradient in the lens. A mutation in the crystallin gene may alter crystallin stability, solubility, or ability to oligomerize and may precipitate from solution, resulting in lens opacity. So, they are considered to be good candidate genes for congenital cataract \[[@r18]\].The vertebrate crystallins are divided into two families: α-crystallins and the β- and γ-crystallin families \[[@r19],[@r20]\]. The β- and γ-crystallins share a commonly features anti-parallel β-sheets in the proteins, referred to as the "Greek key motif." All vertebrate lens β-crystallins consist of two domains and each one folds into two similar "Greek key motifs," with each "Greek key motif" comprised of four consecutive anti-parallel β-strands \[[@r21]\].

The *CRYBA3/A1* gene uses an alternative translation initiation site to encode both the βA3- and βA1-crystallins.The βA3-crystallins are longer than the βA1-crystallins by the addition of 17 amino acids at the 5′-terminal end \[[@r22]\]. An intermediate form of the βA3-crystallin gene has an N-terminal arm shortened by 8 amino acids \[[@r23]\]. The βA1-crystallin aggregates ranged from dimers to octamers and further complexity is related to temporal and spatial regulation of expression as well as posttranslational modifications \[[@r24]\].

The *CRY*B*A3/A1* gene consists of six exons: the first two exons encode the N-terminal arm, and the subsequent four exons are responsible for the Greek key motifs \[[@r25]\]. So far, four mutations within the *CRYBA3/A1* gene was reportedly associated with congenital cataract in different families ([Table 3](#t3){ref-type="table"}).One is the c.215+1G\>A mutation which we reported here, another is the c.215+1G\>C \[[@r26]\], the third type is c.215+1G\>T \[[@r27]\],and the fourth is a 3-bp deletion at positions 279--281 (c.279_281del) in exon 4, which causes an in-frame deletion of a glycine residue at position 91 (p.Gly91del) \[[@r28]-[@r31]\].

###### Previous *CRYBA3/BA1* gene mutations associated with congenital cataracts.

  **Bp exchange**   **Aa exchange**        **Biologic consequence**                                       **Origin of family**   **Reference**
  ----------------- ---------------------- -------------------------------------------------------------- ---------------------- ---------------
  c.215+1G\>A       Splice site mutation   zonular lamellar opacities cataract and floriform              Indian                 \[[@r6]\]
  c.215+1G\>C       Splice site mutation   pulverulent, star-shaped, shieldlike and radial cataract       Brazilian              \[[@r26]\]
  c.215+1G\>T       Splice site mutation   Y-suture, nucleus and cortical cataract                        Chinese                \[[@r27]\]
  c.215+1G\>A       Splice site mutation   Y-sutural,mild nucleus and cortical dot cataract               Australian             \[[@r32]\]
  c.215+1G\>A       Splice site mutation   progressive childhood nucleus and peripheral cortex cataract   Chinese                \[[@r33]\]
  c.215+1G\>A       Splice site mutation   posterior polar cataract                                       Chinese                \[[@r34]\]
  c.215+1G\>A       Splice site mutation   zonular cataract with sutural opacity                          Indian                 \[[@r35]\]
  c.279_281del      p.Gly91del             nuclear cataract                                               Chinese                \[[@r28]\]
  c.279_281del      p.Gly91del             pulverulent nuclear congenital cataracts                       Chinese                \[[@r29]\]
  c.279_281del      p.Gly91del             pulverulent lamellar congenital cataracts                      Chinese                \[[@r29]\]
  c.279_281del      p.Gly91del             nuclear cataract                                               Swiss                  \[[@r30]\]
  c.279_281del      p.Gly91del             lamellar cataract                                              Britain                \[[@r31]\]

Previously, five geographically distinct families have been reported to possess the c.215+1G\>A mutation, which is associated with diverse phenotypes including zonular, lamellar, nuclear, cortical,sutural, and posterior polar cataract \[[@r6],[@r32]-[@r35]\].Diverse cataract phenotypes caused by exactly the same mutation within *CRYBA3/A1* in different ethnic backgrounds suggest that ethic background including environmental factors or, more likely, other genetic modifiers may influence the expression and function of this gene in lens development and cataract formation. In the family we studied, the phenotypes show considerable variation in morphology, and the severity of the disease ranged from requiring surgery to unawareness of the affliction before this study. Of the four patients who had pictures of their affected eyes taken,II:1 (nuclear cataract with 'Y' sutural) and IV:2 (zonular cataract with 'Y' sutural), are more severe than III:3 (mild nuclear cataract) and IV:1 (simple 'Y' sutural cataract). In addition, after a 5-year followed up of this family, we found the opacities of lens in the affected individuals are not progressive. So, the phenotype of this family was identified as polymorphic.Splice-site mutation is a genetic mutation that inserts or deletes several nucleotides at the splice junction during mRNA processing. It was reported to contribute to exon skipping, activation of cryptic splice sites, creation of pseudo-exon within an intron, or intron retention, which commonly results in exon skipping \[[@r36]\].As speculated by Kannabiran et al. \[[@r35]\], the c.215+1G\>A mutation (position 474) would result in skipping of a donor splice junction, recruitment of a cryptic splice site (position 460),or possibly both. All possibilities would cause improper folding of the first Greek key motif, which leads to structural instability of βA1/A3-crystallin and subsequent cataract formation.

Conclusions
-----------

In conclusion, we have identified a polymorphic form of congenital cataracts associated with a c.215+1G\>A mutation of the *CRYBA1/A3* gene in a Chinese family. This mutation supports the role of the *CRYBA3/A1* gene in human cataract formation and provides additional evidence for the genetic heterogeneity of congenital cataracts in a different ethnic background.
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